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This slndy was designed to investigate whether intracoronary
diltiazem given before reperfusion could enhance myocardial
salvage in the canine heart. Twenty-five dogs were subjected to
90 min of coronary occlusion followed by 4 h of reperfusion . The
dogs were assigned to one of three experimental groups . The early
diltiazem group received intracoronary diltiazem into the distal
coronary bed at the onset of coronary occlusion and for 60 min
after reperfusion. The late diltiazem group received the same
amount of drug beginning 15 min before reperfusion and the
control group received saline solution for 90 min of occlusion and
60 min of reperfusion.
Infarct size expressed as a percent of the area at risk was
significantly smaller in the early and late diltiazem groups (15 .6 ±
3.6% and 21 .2 ± 5 .1%, respectively) than in the control group
(49 ± 4.6%) p < 0.05) .
Intracoronary dillTern restored systolic function of the
stunned, previously ischemic tissue to essentially normal preoc .
Extent of necrosis is a major determinant of prognosis after
acute myocardial infarction and early reperfusion is the best
way to limit infarct size (1-6)
. In the clinical setting, throm-
bolytic agents are making reperfusion in patients with acute
infarction a reality ; however, the usefulness of reperfusion is
often limited by the time elapsed before it can be applied . In
this regard, any therapeutic intervention that could delay the
progression of necrosis and effectively open the window of
opportunity would be of major clinical interest . Prolonging
this time limit for significant reduction of infarct size could
well allow larger amounts of myocardial salvage through
reperfusion .
Diltiazem, a calcium channel blacker, exhibits a myocar-
dial-protective effect through several mechanisms (7-9) . It is
an energy-sparing drug because of its enact on cardiac
contractility, heart rate and peripheral vascular resistance . It
is a coronary vasodilator and therefore increases myocardial
oxygen supply . In addition, by impeding calcium entry
through the slow channels, diltiazem helps to maintain
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elusion values. Segmental shortening after reperfusion averaged
21.6% in the early ditiazem group versus 0 1: 1 .7% and 7.3 :t 4%
for the control and late diltiazem groups, respectively (p < 0
.05).
Low dose intracoronary diltiazem did not alter hemodynamic
variables or myocardial blood flow but did improve segmental
shortening 2 and 6 h after reperfusion .
These data indicate that intracoronary diltiazem given during
occlusion or just before reperfusion increases the salvage of
myocardium compared with the salvage achieved by repertmton
alone. These results also suggest that intraeoronary dOHazem
given during the ischemle period enhances systolic contractile
function of pusnschemic stunned myocardium. Improvement in
function and salvage of myocardium was obtained In The absence
of coronary flow effects, suggesting that diltiazem acts by favor.
ably altering the calcium balance within ischemic myocytes .
(J Am Cog Cordial 1991;18 :86g-75)
normal calcium homeostasis and prevent the calcium over-
load that occurs not only during ischemia, but also with
reperfusion . The beneficial effect of calcium antagonists on
postreperfusion ventricular function after brief transient
coronary occlusion has been demonstrated (10) . The benefit
of giving a calcium antagonist only during reperfusion as
opposed to throughout the ischemic period is not clearly
established .
Accordingly, the purpose of this study was to determine
whether the administration of diltiazem before reperfusion
enhances myocardial salvage in the canine heart . We report
the effects of intracoronary diltiazem when given at the onset
of the ischemic period and when given at the onset of the
reperfusion period.
Methods
Experimental preparation. Twenty-five mongrel dogs
(average weight 25 kg) were studied after premedication with
morphine (2 mg/kg body weight subcutaneously), diphenhy-
dramine (4 mglkg subcutaneously) and succinylcholine
(I mg/kg intravenously) . The dogs were anesthetized with
alpha-chloralose (75-mg/kg intravenous loading followed by
18 mg/kg per h) and morphine (I mg/kg per h subcutaneous-
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Figure 1. Drawing showing the bypass circuit from the left subcla-
vian to the left anterior descending (LAD) coronary artery beyond
the occluding ligature . An infusion pump is located in the bypass
system to allow the infusion of diltiazem or saline solution into the
distal coronary bed during occlusion with the clamp on and during
reperfusion with the clamp removed . Regional myocardial function
was measured by one pair of ultrasonic crystals in the normal
segment and another in the ischemic segment . There IF a catheter in
the left atrial appendage for the introduction of microspheres and a
Millar catheter through the apex of the left ventricle to measure
pressures.
ly). The dogs were intubated and ventilated with a positive
pressure respirator
.
The heart was exposed through a left lateral thoracotomy .
The pericardium was opened and the heart was suspended in
a pericardial cradle . The left anterior descending coronary
artery was dissected distal to the first diagonal branch (Fig
.
11; a suture was passed around the artery for later occlusion .
A bypass system was set up between the left subclavian
artery and the distal left anterior descending artery . An
infusion pump was installed in the bypass system for the
continuous infusion of diltiazem or saline solution
.
A 7F Millar microtipped pressure transducer (model
PC490) was placed in the left common carotid artery to
monitor arterial blood pressure. It was attached to a solid
state bridge amplifier (Validyne model CD19) . The signals
were recorded onto an Apple HE computer with use of an
analog to digital converter (A2 Devices), A fluid-filled cath-
eter was placed in the left atrium and connected to a Gould
P231D transducer to monitor left atrial pressure . Both trans-
ducers were calibrated and balanced before each experi-
ment.
A plastic catheter was placed in the left atrium for the
injection of radioactive microspheres used to measure re-
gional blood flow and Monastml blue dye to delineate
myocardium at risk. Au arterial line was placed in the left
femoral artery for withdrawal of a reference blood sample
during microsphere injection . A 7F Swan-Ganz catheter was
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Figure 2. The experimental protocol consists of a 90-min left
anterior descending (LAD) artery occlusion period followed
by 4 h
of reperfusion. The early diltiazem group received intacoronary
dilliazem for 90 min of occlusion and 60 min of reperfusion . The late
diltiazem group received a similar amount and concentration of
diltiazem, beginning 15 min before reperfusion . A third control
group received inlmcoronaey saline solution for 90 min of occlusion
and 60 min of reperfusion .
placed in the pulmonary artery to measure cardiac output
with an Edwards model 9520A cardiac output computer
.
Two pairs of ultrasonic crystals (Electrosonic, Inc
.) were
implanted in the left ventricle to assess regional myocardial
function. Each crystal pair was inserted subendocardially,
approximately I cm apart, in a circumferential plane . One
crystal pair was implanted in the area to be rendered
ischemic (determined by epicardial cyanosis after temporary
left anterior descending artery occlusion). The other crystal
pair was implanted in normally perfused myocardium (terri-
tory of the circumflex artery) . The crystals were connected
to a sonomicrometer (Triton Corp ., model 120) . Segmental
lengths from each region were recorded an the Apple HE
computer after digitization .
A continuous infusion of xylocaine (2 mg/min) was given
throughout the experiment, with a bolus injection (I mg/kg)
given before occlusion and before reperfusion
. The dogs
were allowed 15 min after surgical preparation to reach a
steady state. To begin the experiment, the ieft anterior
descending artery was occluded with the ligature and during
the occlusion period the bypass system was closed off .
Protocol. Infarction was produced by 90 min of left
anterior descending artery occlusion, followed by 4 h of
reperfusion (Fig. 2) . The dogs were assigned to one of three
experimental groups : early dilliazem, late diltiazem or con-
trol
. In the early diltiazem group, diltiazem (generously
supplied by Nordic Laboratories. Inc .) was infused into the
distal left anterior descending artery at the onset of coronary
occlusion . The rate was 20 yug/kg per min for 15 min, then
10 µg/kg per min for an additional 135 min
. The dose of
diltiazem was selected to minimize hemodynamic alterations
and yet be sufficient for effective calcium channel blockade .
The dose used was similar to that used in previous experi-
mental studies (11-13) and did not produce sigotlicant hypo-
tension, myocardial depression or atrioventri utar conduc-
tion delay.
In the (ate dilriazem group, dilliazem was infused into the
distal left anterior descending artery, beginning 15 min
before reperfusion. The rate and concentration of diltiazem
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used were the same as in the early diltiazem group . The
control group received saline solution for 90 min of occlusion
and 60 min of reperfusion . All dogs had the same volume of
saline solution administered into the left anterior descending
artery . These experiments conformed to the "Position of the
American Heart Association on Research Animal Use,"
adopted November 11, 1984
.
Assessment of regional myocardial blood flow . Flow was
assessed with 15 a- 3 yum radioactive microspheres (3M
Nuclear Products) labeled with either tin-I13, strontium-85
or scandium-46 . The standard reference withdrawal method
was used to assess regional flow and 3 to 4 million micro-
spheres were injected for each flow determination . Flow was
assessed after 90 min of occlusion . 20 min of reperfusion and
240 min of reperfusion .
After death . transmural tissue blocks were removed from
the normal and ischemic zones . The blocks were then
subdivided into endocardial and epicardial regions . The
tissue was analyzed with a Beckman gamma counter for the
distribution of the microspheres. From these measurements,
the radioactivity per gram of tissue was determined and
myocardial blood flow was calculated by standard tech-
niques (14) . Myocardial blood flow was expressed as milmin
per g .
Assessment of area at risk and infarct size . When the
experiment was completed, an in vivo area at risk was
determined by injecting Monastral blue dye (1
.5 ml/kg) into
the left atrium, with the left anterior descending artery and
bypass circuit occluded. The heart was excised and the left
ventricle was isolated and sliced into 1-cm sections . A clear
acetate overlay was placed over the heart slices, Myocar-
dium not stained blue (that is, area at risk) was traced . The
slices were then incubated in Sorensen's buffer (0.1 M,
pH 7 .4) and nitro blue tetrazolium chloride to determine the
area of infarction (15) . The unstained infarct area was
similarly traced onto an acetate overlay . The acetate tracings
were drawn in a blinded fashion . Area at risk and area of
infarction were determined by planimetry of the tracings .
Infarct size was expressed as a percent of the left ventricle
and as a percent of area at risk
.
Assessment of regional myocardial function
. Regional
myocardial function was assessed by ultrasonic crystals with
use of standard techniques (16). End-diastolic length (EDL)
was defined as the crystal separation at the onset of the R
wave on the electrocardiographic (ECG) tracing
. End-
systolic length (ESL) was defined as the crystal separation at
the time of the dicrotic notch of the carotid artery pressure
tracing. Regional myocardial function was expressed as
percent systolic shortening (%SS) and calculated as follows :
(EDL - ESL\
%SS
EDL
/
I x loo%.
In the event of ischemia, the segment lengthened rather
than shortened. This is referred to as systolic bulging (17) .
Maximal systolic length (MSL) was defined as the widest
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point of crystal separation during systole . Regional percent
bulging was calculated as follows :
/
.SL
- EDL\
% Bulging = x 100% .
EDL
Percent ;shortening and percent bulging were calculated
before occlusion, at 90 min of occlusion and at 120 and
240 min of reperfusion.
Statistical analysis . Data are expressed as the group mean
values '_ SEM . Hemodynamic variables, blood flow, infarct
size and regional function were analyzed by using multivari-
ate analysis and analysis of variance to determine if there
was a significant difference among the three groups . A
Student's Newman-Keuls test was then applied to determine
at which point the differences occurred . Differences were
considered significant at the p < 0 .05 level.
Dogs with a high rollateral flow to the ischemic region
and a small area at risk were excluded from analysis . The
specific criterion was >0 .25 ml/min per g flow to the en-
docardium in the "ischemic" bed .
To assess the relative influences of treatment, epicardial
collateral flow and myocardial oxygen demand, forward
stepwise multiple linear regression analysis was performed
such that : infarct size (as a percent of area at risk) = a u + b l
x treatment(o) + b
2
(heart rate x blood pressure) + b3 x
(subepicardial ischemic blood flow), where treatment = I if
diltiazem was given and 0 if otherwise . In this way, the
independent effects of treatment could be assessed in addi-
tion to the indirect effects treatment may have had on
myocardial oxygen demands a^d collateral flow .
Results
The three study groups . Of the 25 dogs initially entered in
this study, 8 were excluded
. One dog was excluded because
of failure to cannulate the left anterior descending artery .
Four dogs died of ventricular fibrillation . Of the four dogs
that died, two were in the control group, one was in the early
diltiazem group and the other was in the late diltiazem group .
Three dogs did not sustain an infarction and were considered
atypical of the overall study group . After these exclusions,
five dogs remained in the control group, five in the early
diltiazem group and seven in the late diltiazem group.
Hemodynamics (Table I) . There was no significant differ-
ence among groups with regard to systolic arterial pressure,
left atria) pressure, heart rate or cardiac output during
coronary occlusk'st and after reperfusion. Systolic blood
pressure decreased in all three groups over time, slightly
more in the dilliazem-treated groups . Most important, the
hemodynamic values during the occlusion and reperfusion
periods were similar in the early- and late-treated dilliazem
groups .
Regional myocardial blood flow (Table 2) . At 90 min of
occlusion, there was a marked decrease in coronary blood
flow to the ischemic compared with normal myocardium.
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Table 1 . Hemodynamic Variables for Control and Dilnazom-1, 'oicd Groups
*p
10 .05
versus preveatmenl .
Cardiac oinput alirervmint
Control
Early dihiazm
Late dill-c .
Endocardial blood how to the ischemic zone was similar in
all groups . At 20 min of reperfusion . there was a significant
increase in regional myocardial blood flow, but there were
no significat differences among the three groups . By
240
min
of
reperfusion. there were still no differences in
regional myocardial blood flow among the groups .
Infarct size (Fig. 3) . Infarct size expressed as a percent of
the left ventricle was significantly smaller in the early and
late diltiazem groups (2 .7 zt 0 .77 and 6.3
.
1 .67 . respec-
Table 2. Regional Myocardial Blood Flow for Control and
Diltiazem-Treated Groups Imllmin per g tissue)
Value, are e,prcncd a, moon , :due,
-
SEht . Endo = oIducxrdam
.
Ept = eplca,da m .
3.9-07 24-(I.3 30-0.1 30-1 .1
3.A-0 . 2 29
.0 .
.0,
, ;
.0,
17
	
0.3 '_ .8-0 .4 2 -.-403
tively) than in the control group 112.3 ± 2 .3`3 I (p < 0
.05) .
There was no significant difference between the early and
late diltiazem groups . Infarct size was also expressed as a
percent of the area at risk . There was a significant reduction
in the early and late dilliazem groups (15 .6 ± 3 .6% and
21 .2 5 .1` . respectively) compared with the control group
149 - 4 .6`71 (p < 0 .05) . There was no significant difference
bet-en the early and late diltiazem groups .
[lie to adtt n( nudtiple Ifnear regression analysis are
slunrn in Table 3 . The variable that explained most of the
variance was treatment with diltiazem
. The heart rate-blood
pressure product was also a significant factor, although it
explained only a third of
the variance that treatment did .
Subepicardial blood flow was not significant .
Regional myocardial function (Fig . 4) . After 90 min of
occlusion
. systolic shortening in the ischemic segment de-
Figure 3. Effect of different diltiazem treatments on infarct size
expressed as a percent of the left ventricle (LV) and a percent of the
area at risk after 91) min of ischemia and 4 h of reperfusion .
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Table 3. Multiple Lincur Regression Analysis' of the fa :Iors
Influencing Infarct Size
Variable Coefcienl AP p value
Tsatmcn1 -23 .8215 .991 0.48 0 .002
Rao-prerwrc proJucl 0.002 (000)1 0.16
0 .05
Suhepicardiul blood flow
-15 .02 (14 .58
)
0.02 NS
'Multiple r value
= 0.81: a = 17 .7 ; constant = 16.67 . Infarct size = au +
b l x roatmenl 11;1 + h, x Irate x pros are) 4 b, x Isubepicanhall irehemie
blood fowl, where tremment = I when diltiazem was given and 0 if . control
animal.
creased markedly in all three groups . There was no signifi-
cant difference among the groups 90 min after occlusion .
With reperfusion, all groups showed some improvement ;
however, significant improvement was only noticed in the
group given diltiazem during occlusion . After 4 h of reper
fusion, systolic shortening was significantly greater in the
early diltiazem group than in the late dilliazem and control
groups . The administration of dilliazem only during reperfu-
sion did not significantly improve regional myocardial func-
tion.
Figure 5 illustrates percent systolic bulging in the isch-
emic segments . Before coronary occlusion, ventricular func-
tion was normal and no bulging occurred . After 90 min of
occlusion, systolic bulging occurred to the same extent in all
groups . With reperfusion
. bulging decreased in all groups .
However . at 120 and 240 min of reperfusion, percent bulging
was significantly less in the early diltiazem group than in the
late diltiazem and control groups . Late diltiazem treatment
did not significantly improve the systolic bulging in ischemic
segments .
Systolic shortening wa.n measured in the control circum-
flex artery led f treated and control dogs . There was no
significant change in percent shortening of the control seg-
ment 90 min after occlusion nor was a significant change
noticed at 120 and 240 min of reperfusion
. There were no
Figure 4
. Mean percent segmental shortening in the ischemic left
anterior descending coronary bed
. Measurements were obtained
before occlusion, 90 min after occlusion and 120 and 240 min after
reperfusion for all three groups .
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5. Mean percent systolic bulging in the ischemic left anterior
descending coronary bed expressed as a percent of baseline end-
diastolic length . Measurements were obtained before occlusion,
90 minutes after occlusion and 120 and 240 min after reperfusion for
all three groups .
significant differences among the three groups at any time
with regard to regional function in the control area .
Figure 6 demonstrates
pressure-length
loops taken from
the ischemic segment ofa control dog . Before occlusion, the
normal loop rotates counterclockwise and after occlusion is
replaced with the development of dyskinesia, lengthening as
pressure increases, with a total loop area near 0, suggesting
passive deformation with no work performed . With reperfu-
sion, there is no improvement and at 4 h, there continues to
he marked dyskinesia.
Figure 7 illustrates a pressure-length loop taken from the
ischemic segment in a dog treated with inrracoronary dilt-
inzem during
occlusion and rperfusian . The normal loop is
Flgure6
. Left ventricular ILVI pressure-length loops taken from the
ischemic segment in a control animal . Each loop represents a
different time after occlusion or reperfusion . The control loop is
represented by a solid line drawing.
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Figure 7
. Left ventricular ILV)pressure-length loops taken from the
ischemic segment in an animal given diltiazem throughout occlusion
and for 60 min of reperfusion
. Each loop represents a different time
after occlusion or reperfusion . The control loop is represented by a
wild line drawing .
replaced by systolic lengthening, which is most marked
90 min after occlusion. Two hours after reperfusion . there is
a return of active systolic shortening and increased stroke
work relative to the occlusion period.
Discussion
The results of this study indicate that the administration
of intracoronary diltiazem during occlusion or just before
reperfusion increases the salvage of myocardium compared
with salvage achieved by reperfusion alone
. The results also
suggest that diltiazem must be given during the ischemic
period to improve early myocardial function .
Previous studies
. Diltiazem and other calcium channel
antagonists have been shown (8,11,18-27) to be useful in
limiting infarct size . There are several reasons why diltiazem
might be beneficial
. Diltiazem may favorably alter the bal-
ance between myocardial oxygen supply and demand by
improving perfusion or decreasing oxygen consumption, or
both . There also may be a cellular protective effect with
calcium channel antagonists . Myocardium reversibly injured
by 10 min of transient ischemia does not accumulate cal-
cium. However, 40 loin of ischemia followed by reperfusion
results in severalfold augmentation of calcium (23) . This
intracellular calcium accumulates in mitochondria and mito-
chondria overloaded with calcium exhibit profound func-
tional abnormalities. Information published to date suggests
that these mechanisms may all be operative and the impor-
tance of each may be dependent on the model that is
examined. We did not find any significant difference in blood
flow among the three groups, suggesting that diltiazem did
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not significantly increase collateral flow during the ischemic
period . Diltiazem-treated groups experienced a decrease in
systolic blood pressure that may have contributed to re-
duced oxygen demand
. The lack of a significant difference
among the three groups suggests that this was not the
primary mechanism whereby diltiazem was effective in
augmenting myocardial salvage induced by reperfusion .
Role of treatment, collateral flow and myocardial oxygen
demand. We used a multiple linear regression technique to
assess the relative influences of treatment. collateral flow
and myocardial oxygen demand (rate-pressure product) sim-
ilar to the technique used by Reimer and Jennings (24)
.
This
type of analysis allows assessment of both the independent
and secondary effects that treatment might have had on
collateral flu, and myocardial oxygen demands (Table 3) .
The analysis confirms a strong independent treatment effect
irrespective of any secondary effects . It also suggests that
collateral flow had vet-v little influence on infarct size and
that the rate-pressure product had a smaller influence . Con-
firmation of the importance 'tf an independent treatment
effect suggests a cellular role .
Protective effects of diRiazem during ischemic . The direct
cellular protective effect of diltiazem during ischemia and
reperfusion has been proposed by several publications
(12.13 .21 .25 26). These studies suggest That this protective
effect is independent of flow and hemodynamic changes and
is most likely related to a direct effect limiting intracellular
calcium. As expected, this protective effect disappears after
prolonged periods of ischemia that result in marked struc-
tural changes in the sarcolemma and an inability to control
calcium homeostasis
. With 90 min of coronary occlusion
followed by reperfusion, this mechanism is the most likely
explanation for the result:, in our study . It is also possible
that calcium channel antagonists may decrease the genera-
tion of toxic oxygen free radicals, which have been impli-
cated in the pathogenesis of postischemic tissue injury (27) .
Prevention of reperfusion injury . The calcium channel
blockers are valuable not only in ischemic myocardium, but
also play a more important role in the prevention of reper-
fusion injury . This may be secondary to the prevention of
massive calcium influx observed during reperfusion . In this
study . diltiazem given only during reperfusion augmented
myocardial salvage induced by reperfusion . suggesting that
prevention of
reperfusion injury was an important mec ..a-
nism
. The mechanisms involved in the cellular uptake of
calcium during reperfusion are not completely known . Cal-
cium enters the myocyte because of increased permeability
of the sarcolemma (28) . Calcium may also enter the cci!s by
sodium-calcium exchange or slow calcium channels that are
voltage-dc;
endent. A study by Klein et al. (22) demon-
strated that reperfusion injury could be attenuated by dilt-
iazem given during the first 45 min of renerfusion in a porcine
model with 45 min of occlusion and 3 days of reperfusion .
Restoration of regional myocardial function after reperfu-
sion . Intracoronary diltiazem in this model augmented the
return of regional myocardial function induced by coronary
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reperfusion . If diltiazem was given only during the reperfu-
sion period, this return of myocardial function was nut
observed . Previous studies (29) have demonstrated, how-
ever, that improvement in regional myocardial function may
lake days to weeks after reperfusion . This prolonged post-
ischemic ventricular dysfunction has been termed "stunned
myocardium." It is postulated that an ischcmic insult not of
sufficient severity to produce necrosis may disrupt myocar-
dial ullrastructure and biochemical processes, resulting in
impaired ventricular performance. Over time, these condi-
tions reverse and cardiac function improves . When diltiazem
was given just before reperfusion . there was a significant
reduction in infarct size but continued left ventricular im-
paietncnt
. It is possible that if this group had been examined
several weeks after reperfusion. it may have demonstrated
improved myocardial function .
In our study . diltiazem was given 15 min before reperfu-
sion. Reperfusion injury associated with rapid cell swelling
and destruction of subcellular organelles begins immediately
after reperfusion . This experiment was designed so that
diltiazem would be present in the microcirculation before
reperfusion . We cannot speculate whether administering the
drug immediately after reperfusion would have had a signif-
icant beneficial effect .
We cannot assume from this study that the beneficial
effects of diltiazem extend to other calcium channel antago-
nists, There are major differences among the clinically
available calcium antagonists . Diltiazem was chosen fur this
experiment because of its demonstrated effect in other
models to enhance myocardial salvage . Dilliazem has been
shown (30) to maintain adenosine triphosphate stores and
reduce the accumulation of lactate and free fatly acids. It has
also been demonstrated (12) to decrease cellular edema,
preserve mitochondrial architecture and act to maintain the
structural integrity of the sarcolemma . Although the results
of this study suggest that diltiazem does enhance the salvage
of myocardium subjected
to reperfusion, extrapolation of the
results to other calcium channel antagonists should be
avoided.
Clinical implications. The demonstration that a drug
given after coronary occlusion and before reperfusion can
increase the benefit expected from repeficaton has important
clinical implications . In this experimental model, diltiazem
was given directly into the ischcmic bud, which makes
clinical extrapolation more difficrit ; however, a drug with a
protective effect could be
valuable
in clinical situations in
which patients are at ri k of coronary occlusion . With this
protective effect in place . there could well be an increase in
the benefit expected from subsequent reperfusion should
occlusion
occur. Such high risk conditions include the
postftbrinolytic-lre
:ded patient or the patient with unstable
angina, early rostinfarction angina or non-Q wave
infarc-
tion. Direct intracoronary injection of diltiazem may also be
valuable when coronary artery bypass grafting or percula-
neous angioplasty is used to reperfuse the acutely ischemic
myocardium. The value of such an agent during prolonged
JAC'C V.I . 18. No 3
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aortecoronary bypass procedures also deserves investiga-
tion, but perhaps the most clinically relevant application is a
suggestion that diltiazem may enhance the salvage of myo-
cardium when combined with a thrombolytic agent in the
setting of acute myocardial infarction .
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